These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 11003021)

  • 1. Cardioplegic solution challenges.
    Menasché P
    Ital Heart J; 2000 Sep; 1 Suppl 3():S40-2. PubMed ID: 11003021
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardioplegic solutions and nitric oxide in coronary artery bypass surgery.
    Türköz R
    Anadolu Kardiyol Derg; 2006 Dec; 6(4):352. PubMed ID: 17162283
    [No Abstract]   [Full Text] [Related]  

  • 3. Transient beneficial effects of glutamate-aspartate-enriched cardioplegia on ventricular functions in coronary artery bypass grafting.
    Duman U; Dogan OF
    J Card Surg; 2006; 21(5):523-5. PubMed ID: 16948778
    [No Abstract]   [Full Text] [Related]  

  • 4. Supplementation of magnesium to warm blood hyperkalemic cardioplegia for the prevention of atrial fibrillation after coronary artery bypass grafting.
    Reşatoğlu AG; Uymaz OK; Akbulut B; Yener A
    Anadolu Kardiyol Derg; 2007 Jun; 7(2):230. PubMed ID: 17513237
    [No Abstract]   [Full Text] [Related]  

  • 5. A technique for infusion of cardioplegic solution in coronary artery bypass with aortic regurgitation.
    Imamaki M; Shimakura T
    J Card Surg; 2004; 19(6):539-41. PubMed ID: 15548188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcome after coronary artery bypass grafting in patients with left ventricular dysfunction: does the type of cardioplegia matter?
    Ibrahim MF; Refaat AA
    Interact Cardiovasc Thorac Surg; 2008 May; 7(3):498. PubMed ID: 18495725
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of different cardioplegic solutions on nitric oxide release from coronary vasculature in diabetic patients undergoing coronary artery bypass surgery.
    Karaca P; Yurtseven N; Enç Y; Aksoy T; Sokullu O; Bilgen F; Canik S
    Anadolu Kardiyol Derg; 2006 Dec; 6(4):347-51. PubMed ID: 17162282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficiency of L-arginine enriched cardioplegia and non-cardioplegic reperfusion in ischemic hearts.
    Kiziltepe U; Tunçtan B; Eyileten ZB; Sirlak M; Arikbuku M; Tasoz R; Uysalel A; Ozyurda U
    Int J Cardiol; 2004 Oct; 97(1):93-100. PubMed ID: 15336814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events.
    Lazar HL; Chipkin SR; Fitzgerald CA; Bao Y; Cabral H; Apstein CS
    Circulation; 2004 Mar; 109(12):1497-502. PubMed ID: 15006999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does intermittent aortic cross clamping decrease the incidence of atrial fibrillation after coronary bypass surgery?
    Akgun S; Ozisik K; Kutsal A; Cobanoglu A
    Heart Surg Forum; 2007; 10(4):E320-4. PubMed ID: 17599884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved myocardial protection during coronary artery surgery with glucose-insulin-potassium: a randomized controlled trial.
    Quinn DW; Pagano D; Bonser RS; Rooney SJ; Graham TR; Wilson IC; Keogh BE; Townend JN; Lewis ME; Nightingale P;
    J Thorac Cardiovasc Surg; 2006 Jan; 131(1):34-42. PubMed ID: 16399292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Combined use of ante- and retrograde cardioplegia: limited efficacy in elective coronary artery bypass].
    Hashimoto K; Onoguchi K; Sasaki T; Hachiya T; Takakura H; Oshiumi M; Takeuchi S
    Kyobu Geka; 2000 Dec; 53(13):1105-9. PubMed ID: 11127556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intraoperative myocardial protection with extracellular cardioplegic solutions in patients with cardiac valve diseases].
    Zhidkov IL; Ivanov VA; Kozhevnikov VA; Charnaia MA; Mukhamedzianova AR; Trekova NA
    Anesteziol Reanimatol; 2007; (2):38-42. PubMed ID: 17563998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Which application, complex or mini cardioplegia?/Cardioplegia by minicardioplegia technique].
    Kirali K
    Anadolu Kardiyol Derg; 2006 Sep; 6(3):289-90; author reply 290-1. PubMed ID: 16943123
    [No Abstract]   [Full Text] [Related]  

  • 15. Glucose-insulin-potassium and tri-iodothyronine individually improve hemodynamic performance and are associated with reduced troponin I release after on-pump coronary artery bypass grafting.
    Ranasinghe AM; Quinn DW; Pagano D; Edwards N; Faroqui M; Graham TR; Keogh BE; Mascaro J; Riddington DW; Rooney SJ; Townend JN; Wilson IC; Bonser RS
    Circulation; 2006 Jul; 114(1 Suppl):I245-50. PubMed ID: 16820580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin cardioplegia for elective coronary bypass surgery.
    Doenst T; Ayres BE; Beyersdorf F
    J Thorac Cardiovasc Surg; 2001 Jun; 121(6):1221-2. PubMed ID: 11385404
    [No Abstract]   [Full Text] [Related]  

  • 17. Invited commentary.
    Jessen ME
    Ann Thorac Surg; 2008 Aug; 86(2):541-2. PubMed ID: 18640331
    [No Abstract]   [Full Text] [Related]  

  • 18. [Comparative evaluation of clinical use of cardioplegic solutions custodiol and konsol in the correction of cardiac valvular diseases].
    Zhidkov IL; Kozhevnikov VA; Ivanov VA; Morozov IuA; Andrianova MIu; Van EIu; Trekova NA
    Anesteziol Reanimatol; 2006; (2):13-8. PubMed ID: 16758937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cardioplegia by minicardioplegia technique].
    Türköz R; Gülcan O; Türköz A
    Anadolu Kardiyol Derg; 2006 Jun; 6(2):178-9. PubMed ID: 16766286
    [No Abstract]   [Full Text] [Related]  

  • 20. Late iatrogenic coronary stenosis after selective intraoperative antegrade myocardial protection for stentless aortic valve replacement.
    Maltais S; El-Hamamsy I; Ducharme A; Carrier M; Pellerin M; Perrault LP
    J Thorac Cardiovasc Surg; 2006 Aug; 132(2):420-1. PubMed ID: 16872972
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.